Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer <sup>68</sup>Ga-Pentixafor for PET
Fabien Hyafil(Inserm), Markus Schwaiger(Unknown)
Cited by 110
Related Papers
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
|The Lancet Oncology|2007|808
Anatomic Versus Physiologic Assessment of Coronary Artery Disease
|Journal of the American College of Cardiology|2013|563
Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric Junction
|Journal of Clinical Oncology|2006|464
Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
|Journal of Clinical Oncology|2004|460
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
|Journal of Clinical Oncology|2003|320